These medications have gained widespread attention for their effectiveness in helping individuals shed significant weight, but Dr
however, there are many factors to consider when evaluating the use of any product for inflammation or autoimmune disease
Wegovy is a glucagon-like peptide-1 (GLP-1) receptor agonist for chronic weight management, along with a reduced calorie diet and increased physical activity, for people with an initial body mass index (BMI) of: 30 kg/m2 or greater (obesity) or 27 kg/m2 or greater (overweight) in the presence of at least one weight-related comorbid condition (e.g., hypertension, type 2 diabetes mellitus, or dyslipidemia)
A popular dual agonist, tirzepatide (Mounjaro), activates both GLP-1R and GIPR, producing synergistic effects on insulin secretion, appetite suppression, and weight reduction (Table 1)
After one to two weeks of treatment, many patients report feeling mentally clearer and emotionally more balanced
For optimal results, take at least 30 minutes before or 90 minutes after a meal with 250 ml of still, lukewarm water or, alternatively, with a teaspoon of omega-3 oil to increase bioavailability